The program is designed to treat complex tumor-multiplying diseases, such as neurofibromatosis 2, schwannomatosis tuberous sclerosis, von Hippel-Lindau disease, Sturge Weber syndrome and hemorrhagic telangiectasia. These disorders are rare and often have no cure.
The program includes a multidisciplinary team that provides ongoing surveillance and coordination of all treatments and check-ups.
More Articles on Hospital Oncology:
Commonwealth Cancer Centers of Kentucky Joins UK Markey Cancer Center Network
Pacific Cancer Institute of Maui to Begin $7M Expansion
Mayo Clinic Names Coborn Cancer Center First Member of New Cancer Care Network
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
